LSE · OPT.L
Optima Health plc
£2.44£0.00 (0.0%)
Optima Health plc’s quoted price sits in the upper half of its reported 52-week range, 7.77% below the high.
Loading market information…
LSE · DXRX.L · GBp
Stock price, earnings
Quote as of Oct 29, 2026, 01:35 PM UTC. Cached market data; not a live quote.
One-year closing-price history · GBp. Historical prices are not a forecast.
Diaceutics PLC’s quoted price sits in the upper half of its reported 52-week range, 3.1% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Diaceutics PLC’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Diaceutics PLC, established in 2005 and headquartered in Belfast, UK, is a company dedicated to accelerating the commercialization of diagnostic solutions. It offers global pharmaceutical companies comprehensive data, advanced analytics, and implementation support. Central to its operations is the DXRX platform. This platform features DXRX data solutions, providing access to extensive diagnostic testing data pipelines from a broad network of laboratories, including real-time DXRX signal alerts, lab and physician mapping, and a testing dashboard. The DXRX platform also hosts a marketplace where laboratories, pharmaceutical firms, and diagnostic companies can connect to collaborate on precision medicine diagnostics. Diaceutics further provides DXRX Patient Journey, a tool for pharmaceutical clients to conduct detailed longitudinal analyses of individual patient biomarker testing paths, helping identify opportunities for earlier intervention and treatment. DXRX Lab Benchmarking allows laboratories to sharpen their competitive edge by comparing their key criteria against industry counterparts, encompassing metrics such as disease focus, testing methodologies, market share, turnaround times, and their standing as leaders in specific diagnostic fields. The DXRX Test Reimbursement service assists pharma clients in funding novel companion diagnostics, thereby shortening the time required for their widespread adoption. Furthermore, DXRX Test Signal delivers immediate notifications of testing events, empowering pharmaceutical clients to swiftly identify therapeutically actionable patients. Beyond the platform, Diaceutics furnishes services for diagnostic landscape analysis, strategic planning, implementation, and ongoing tracking, alongside expert consulting tailored to precision medicine diagnostics. Its extensive service portfolio also covers test standardization, quality evaluations, optimization of test reports, technical laboratory support, assistance with test access and reimbursement, laboratory training, and various educational resources.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 04:06 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Q2 2023 | Sep 26, 2023 | -£0.02 | £9.92M+0.24% vs estimate |
|---|
| Q1 2023 | Apr 18, 2023 | £0.02+25.21% vs estimate | £11.98M-4.19% vs estimate |
|---|
Latest available per-share figures in GBP. The payout ratio compares dividends with earnings.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
£2.44£0.00 (0.0%)
Optima Health plc’s quoted price sits in the upper half of its reported 52-week range, 7.77% below the high.
£0.54+£0.02 (+2.86%)
Beximco Pharmaceuticals Limited’s quoted price sits in the upper half of its reported 52-week range, 16.92% below the high.
£3.35+£0.02 (+0.45%)
Animalcare Group plc’s quoted price sits in the upper half of its reported 52-week range, 1.47% below the high.
£4.05£0.00 (0.0%)
Tristel PLC’s quoted price sits in the upper half of its reported 52-week range, 10.0% below the high.
£0.89£0.00 (0.0%)
Scancell Holdings plc’s quoted price sits in the lower half of its reported 52-week range, 69.83% below the high.
£20.25-£0.25 (-1.22%)
Bioventix PLC’s quoted price sits in the upper half of its reported 52-week range, 10.2% below the high.
£0.24+£0.00 (+1.93%)
EKF Diagnostics Holdings plc’s quoted price sits in the lower half of its reported 52-week range, 18.1% below the high.
£5.30£0.00 (0.0%)
4basebio PLC’s quoted price sits in the lower half of its reported 52-week range, 35.37% below the high.
